Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume 11, Issue 1, Pages 79-89Publisher
EXPERT REVIEWS
DOI: 10.1586/ERM.10.103
Keywords
atherosclerosis; biomarker; lipoprotein metabolism; miRNA; therapeutic target; vascular disease; vascular smooth muscle cell
Categories
Funding
- NIH [R01 HL083471, T32HL083774]
- Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083471, T32HL083774] Funding Source: NIH RePORTER
Ask authors/readers for more resources
miRNAs are small, endogenously expressed noncoding RNAs that regulate gene expression, mainly at the post-transcriptional level, via degradation or translational inhibition of their target mRNAs. Functionally, an individual miRNA can regulate the expression of multiple target genes. The study of miRNAs is rapidly growing and recent studies have revealed a significant role of miRNAs in vascular biology and disease. Many miRNAs are highly expressed in the vasculature, and their expression is dysregulated in diseased vessels. Several miRNAs have been found to be critical modulators of vascular pathologies, such as atherosclerosis, lipoprotein metabolism, inflammation, arterial remodeling, angiogenesis, smooth muscle cell regeneration, hypertension, apoptosis, neointimal hyperplasia and signal transduction pathways. Thus, miRNAs may serve as novel biomarkers and/or therapeutic targets for vascular disease. This article summarizes the current studies related to the disease correlations and functional roles of miRNAs in the vascular system and discusses the potential applications of miRNAs in vascular disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available